The trade brain.
One mind for global trade.

I'm the Vametra AI Brain — the trade operating system. Ask me anything about exports, HSN codes, duties, documents, certifications, markets, schemes or business services. I orchestrate 12 trade engines to give you one clear answer.

For HS 300490 (medicaments in dosage form) from India to Greece:

Duty in Greece

• Import duty: 0.0% MFN (applied) for HS 300490, based on the live duty context provided.
• So, on a standard customs-value basis, this line is currently duty-free on import into Greece.
• Note: import VAT and any regulatory charges may still apply in Greece, even when customs duty is zero.

Export benefit from India

• RoDTEP benefit: 0.7% of FOB value for the Indian exporter.
• This is an export incentive from India, not a reduction in Greek import duty.

Documents you should prepare

For this lane, the practical set is:

• Commercial Invoice
• Packing List
• Bill of Lading / Air Waybill
• Certificate of Origin
• useful for customs support even where no FTA preference is needed
• Product regulatory documents for medicaments
• if the product is a finished pharmaceutical, keep product registration / marketing authorization evidence ready
• Manufacturing / batch documents
• batch details, expiry, composition, and shelf-life evidence are typically important
• Insurance certificate if insured separately
• LC documents if payment is under letter of credit

India-side compliance

• IEC is mandatory for export
• GST registration is needed if you are exporting as a GST-registered entity and claiming refunds / zero-rated export treatment
• RCMC is needed if you want to claim DGFT-linked export incentives like RoDTEP
• Shipment will be filed through ICEGATE

Greece / EU practical compliance points

Because this is a pharmaceutical product, customs duty being zero does not mean automatic market access. You should verify:

• whether the product is a regulated medicinal product or a formulation exempt from full pharma registration
• EU/Greece marketing authorization requirements
• labeling in the required language
• GMP / manufacturing compliance
• if applicable, batch release / stability / shelf-life documentation
• if the consignee is an importer of record, they may need local pharma import permissions

Benefit summary

• Greece import duty: 0%
• India export benefit: RoDTEP 0.7% of FOB
• Commercial advantage: strong, because the destination duty is nil and India still gets a small export incentive

If you want, I can also give you:

1. a customs document checklist for pharma exports to Greece, or

2. a landed-cost estimate including VAT and clearing charges.